2-aminoindan has been researched along with Binge Alcohol Consumption in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Ari, Y; Gal, O; Golan, E; Shimshoni, JA; Sobol, E | 1 |
| Edery, N; Golan, E; Nutt, D; Shimshoni, JA; van Wettum, R; Winkler, I | 1 |
2 other study(ies) available for 2-aminoindan and Binge Alcohol Consumption
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent.
Topics: Administration, Intravenous; Administration, Oral; Animals; Binge Drinking; Brain; CHO Cells; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Humans; Indans; Male; Rats; Rats, Sprague-Dawley | 2018 |
Toxicological evaluation of 5-methoxy-2-aminoindane (MEAI): Binge mitigating agent in development.
Topics: Animals; Binge Drinking; Body Weight; Brain; Drug Discovery; Drug Evaluation, Preclinical; Female; Hepatocytes; Humans; Indans; Male; Rats; Rats, Sprague-Dawley; Toxicity Tests, Subacute | 2017 |